Idiopathic retinal vasculitis, aneurysms, and neuroretinitis in a patient with antiphospholipid syndrome

Archives of Ophthalmology

Volumn 130, Issue 2, 2012, Pages 257-258

  Kurz, Daryl E ^a   Wang, Robert C ^b   Kurz, Paul A ^c,d  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

AGED; ANEURYSM; ANTIBODY TITER; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLURRED VISION; CASE REPORT; HUMAN; MALE; NEURORETINITIS; PRIORITY JOURNAL; RETINA HEMORRHAGE; RETINA VASCULITIS; RETINITIS; SCREENING TEST; VISUAL ACUITY;

AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; ARTERIOVENOUS FISTULA; CAPILLARY PERMEABILITY; FLUORESCEIN ANGIOGRAPHY; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; PARTIAL THROMBOPLASTIN TIME; RETINAL HEMORRHAGE; RETINAL VASCULITIS; RETINAL VESSELS; RETINITIS; VISUAL ACUITY;

EID: 84863153536     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopthalmol.2011.1363     Document Type: Article

References (5)

1. Chang TS, Aylward GW, Davis JL, et al. Idiopathic retinal vasculitis, aneurysms, and neuro-retinitis: Retinal Vasculitis Study. Ophthalmology. 1995; 102(7):1089-1097.
2. Samuel MA, Equi RA, Chang TS, et al. Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology. 2007;114(8):1526-1529, e1.
3. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.
4. Urbanus RT, de Groot PG. Antiphospholipid antibodies: we are not quite there yet. Blood Rev. 2011;25(2):97-106.
5. Pierangeli SS, de Groot PG, Dlott J, et al. "Criteria" aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010. Lupus. 2011;20 (2):182-190.